Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: irinotecan hydrochloride
Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)